Digital medicine company Akili has snapped up Foundation Medicine and ArcherDx veteran Matt Franklin as its new president and COO. He'll oversee the marketing and launch strategy for the world's first ...

The gaming industry has long claimed that its products can have a positive effect on people, and now one group is putting that to the test. Akili Interactive Labs wants to see how well its games work ...

In 2013, Nature told the world that NeuroRacer, the first health game from the research lab that would spin out to become Akili Labs, was a game changer. While Akili Labs cofounder and Chief Science ...

Akili Interactive (“Akili” or “Company”), maker of the first and only prescription video game treatment, today introduced new gaming features and functionalities to its EndeavorRx ? treatment ...

In the not-so-distant future, will playing video games be part of the prescription for treating children with attention-deficit/hyperactivity disorder (ADHD)? That's ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

When it comes to Alzheimer's research, success stories are few and far between. Akili Interactive Labs wants to try a different approach: The Boston-based startup ...

Akili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category ...

One day—and it might not be that far off—doctors could be prescribing what seems an unlikely treatment for ADHD: Play a video game over and over. That’s the aim of Akili Interactive Labs, a ...

Akili Interactive Labs has partnered with the nonprofit Autism Speaks to conduct a clinical trial of its cognitive assessment and personalized treatment video game. This is the latest in a clutch of ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its ...